Cargando…
Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia
The impact of statin treatment on the abnormal plasma lipidome of mixed dyslipidemic patients with metabolic syndrome (MetS), a group at increased risk of developing diabetes, was evaluated. Insulin-resistant hypertriglyceridemic hypertensive obese males (n = 12) displaying MetS were treated with pi...
Autores principales: | Meikle, Peter J., Wong, Gerard, Tan, Ricardo, Giral, Philippe, Robillard, Paul, Orsoni, Alexina, Hounslow, Neil, Magliano, Dianna J., Shaw, Jonathan E., Curran, Joanne E., Blangero, John, Kingwell, Bronwyn A., Chapman, M. John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Biochemistry and Molecular Biology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655992/ https://www.ncbi.nlm.nih.gov/pubmed/26486974 http://dx.doi.org/10.1194/jlr.P061143 |
Ejemplares similares
-
MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines(1)
por: Burla, Bo, et al.
Publicado: (2018) -
Adiposity significantly modifies genetic risk for dyslipidemia
por: Cole, Christopher B., et al.
Publicado: (2014) -
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
por: Tenenbaum, Alexander, et al.
Publicado: (2006) -
Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin
por: Srisawasdi, Pornpen, et al.
Publicado: (2021) -
Association of peripheral differential leukocyte counts with dyslipidemia risk in Chinese patients with hypertension: insight from the China Stroke Primary Prevention Trial
por: Liu, Yanhong, et al.
Publicado: (2017)